Incidence and risk of hypertension associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a comprehensive network meta-analysis of 72 randomized controlled trials involving 30013 patients

BACKGROUND: Tyrosine kinase inhibitors (TKIs) have been developed during the last decade that target the vascular endothelial growth factor receptor (VEGFR) are currently being evaluated as treatments for malignant tumors. The increased application of VEGFR-TKIs means that the probability of hyperte...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Bo, Ding, Fengxia, Liu, Yang, Xiong, Geng, Lin, Tao, He, Dawei, Zhang, Yuanyuan, Zhang, Deying, Wei, Guanghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341903/
https://www.ncbi.nlm.nih.gov/pubmed/27602778
http://dx.doi.org/10.18632/oncotarget.11813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341903/
https://www.ncbi.nlm.nih.gov/pubmed/27602778
http://dx.doi.org/10.18632/oncotarget.11813

Ejemplares similares